Eric J. Ende - 01 Jan 2022 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
Director
Signature
/s/ Dietrich Stephan, as attorney-in-fact for Eric Ende
Issuer symbol
NBSE
Transactions as of
01 Jan 2022
Transactions value $
$0
Form type
4
Filing time
05 Jan 2022, 15:05:17 UTC
Previous filing
02 Nov 2021
Next filing
31 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBSE Stock option (right to buy) Award $0 +165,803 $0.000000 165,803 01 Jan 2022 Common stock 165,803 $2.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the total shares shall vest on the first anniversary of the grant date, and 1/36th of the remaining shares shall vest on a monthly basis thereafter.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.